Liofilchem launches FDA cleared and IVDR compliant antibiotic disc
The new Gepotidacin GEP 10 disc supports antimicrobial susceptibility testing for Enterobacterales, E. faecalis, and S. saprophyticus in clinical microbiology laboratories.
See the latest news and media coverage for Liofilchem. We track all announcements, press releases, and industry mentions in real time, all in one place.
Manufacturer of clinical and industrial microbiology products
liofilchem.comLast updated
In short: Liofilchem launched an FDA-cleared, IVDR-compliant gepotidacin disc and announced FDA clearance for its MTS.
The new Gepotidacin GEP 10 disc supports antimicrobial susceptibility testing for Enterobacterales, E. faecalis, and S. saprophyticus in clinical microbiology laboratories.
The agar enhances contrast for easier reading of inhibition zones, reducing errors, and is recommended by EUCAST for fastidious bacteria.
The MTS and disc are in-vitro methods for antimicrobial susceptibility testing of Gram-negative Enterobacterales.
The MTS determines susceptibility of Enterobacterales to Gepotidacin, with proven performance for key organisms.
In any environment where microbiological quality is critical (food industry, pharmaceutical, cosmetic, hospital or control laboratories) the...
Track Liofilchem and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to Liofilchem and other trending companies.